U.S. Clinical Nutrition Market

U.S. Clinical Nutrition Market is valued at USD 11.8 Billion in 2021 and is expected to reach USD 20.1 Billion by 2028 with a CAGR of 8% over the forecast period.

U.S. Clinical Nutrition Market: Size, Trends, Competitive, And Historical & Forecast Analysis, 2022-2029: Growing elderly population base, rising birth rates, and increasing occurrences of persistent illnesses like cancer, diabetes, and breathing illnesses amongst others are some of the key drivers propelling the worldwide clinical nutrition industry's expansion.

Scope-

Clinical nutrition is a newer subject that has risen in popularity over the last generation. Due to underrecognized malnourishment among hospitalized patients due to the lack of proper healthcare facilities and medical negligence the healthcare sector has begun to place a growing amount of focus on this issue.

Clinical nutrition mainly includes nutrition and dietetics as academic disciplines. Clinical nourishment is largely concerned with the avoidance, detection, and treatment of nutritional alterations in individuals who have chronic illnesses and disorders. Additionally, therapeutic nutrition attempts to keep patients' glucose levels in a healthy range while also giving them enough quantities of nutrients including vitamins, protein, and minerals.

COVID-19 Impact-

COVID-19 has had a substantial influence on the expansion of the clinical nutrition industry. Due to increasing number of infected patients, hospitals were overcrowded which in turn made it difficult for the healthcare providers to accommodate their nutritional needs.  On the other hand, medical experts urged everyone to consume nutritious diet in order to  enhance  their immune system and escape severe infection. This is turn pushed healthcare providers to adopt efficient clinical nutrition practices to ensure faster recovery for COVID-19 patients along with the ones suffering from other ailments.

The Clinical Nutrition and Metabolism guidelines announced by the American Society for Clinical Nutrition and Metabolism's in 2020 mandated nutritional therapy of people with coronavirus infections. This in turn created lucrative growth prospects for this marketplace.

Key Players-

The major players characterizing the competitive terrain of this business vertical are -

• Nestlé SA
• Danone
• Abbott Laboratories
• B. Braun Melsungen AG
• Pfizer
• Baxter Healthcare Ltd.
• Hospira
• Fresenius Kabi
• Perrigo Company PLC.
• Mead Johnson Nutrition Company

Segmentation-

By Product

• Infant Nutrition

  • Soy Based
  • Milk Based
  • Organic Formulas

• Enteral Nutrition

  • Disease Specific Composition
  • Standard Composition

• Parenteral Nutrition

  • Amino Acids
  • Carbohydrates
  • Fats

By Application

• Metabolic Disorders
• Cancer
• Gastrointestinal Disorders
• Neurological Diseases

By Consumer

• Pediatric
• Adult

By Distribution Channel

• Pharmacies & Drug Stores
• Retail Stores
• Online Channels

Market Drivers-

Increasing elderly population Across U.S. is Expected to Propel Market Growth over the Forecast Period:

The expanding elderly demographic is more likely to acquire metabolic diseases as a result of several age-related physiological processes, which is predicted to increase  the need for clinical nutrition, accelerating industry expansion.

For instance, 54.1 million Americans were over the age of 65 in May 2021, based on the 2020 Profile of Older Americans report released by the Administration for Community Living. According to projections, the population will reach 80.8 million in 2040 and 94.7 million in 2060. Throughout the projected period, this is expected to accelerate industry development.

The senior demographic is more susceptible to illnesses that call for clinical nourishment, driving the market's expansion throughout the projected timeframe. For example, 6.2 million Americans aged 65 and older had Alzheimer's disease in 2021, as per statistics from the Alzheimer's Association.

Increasing Government Standards, Initiatives, For Improving Low Weight Birth Rate Sector Are Expected To Propel Market Development:

There has been a steep rise in the number of underweight new-borns across the nation. . In the US, one in every twelve births has a low birth weight  ratio. For U.S. clinical nutrition industry participants, rising new-born birth percentages with low birth weight provide considerable industry development prospects in milk-based nutritional supplements. Milk-based nutritious goods are increasing in recent years since novel product delivery has been made possible by rising needs and fierce rivalry among market participants.

The US FDA granted Fortini, a brand-new newborn nourishment product, clearance in 2021 for the North American-based company Nutricia (by Danone). This medication is designed to help kids who are at risk of having growth deficits and who need more energy.

Market Restraints-

Negative side effects such as Liver failure coupled with Government Stringent Regulations Are Factors Expected To Hinder Market Growth:

The negative effects and difficulties brought on by excessive usage of goods approved for clinical nutrition are the main issues that are anticipated to impede industry expansion in the United States for clinical nourishment. Each nutritional substance taken in excess might cause problems that pose a danger to one's life.

For example, prolonged intravenous nutritional treatment intake might result in severe and perhaps fatal disorders including liver failure. High blood pressure, excessive cholesterol, strokes, cardiovascular disease, and osteoporosis are just a few of the major adverse consequences of clinical nutrition that are likely to prevent more people from using it.

Nevertheless, regulatory agencies have imposed severe regulations on the selling of therapeutic nutrition supplements. According to the DSHEA (Dietary Supplement Health and Education Act of 1994), the U.S. Food as well as Drug Administration, for instance, has more restrictions for clinical nutrition supplies than it does for other things like medications and regular meals. This restrictive regulatory environment for nutritional supplements is expected to hamper the growth of the market.

News-

Fresenius Kabi Launched KabiCare Nutrition Resources in the United States

On December 5^th, 2022; As part of its KabiCare patient care program, Fresenius Kabi announced that KabiCare Nutrition Resources have been made available in the United States. The KabiCare Nutrition Resources program offers assistance with insurance reimbursement issues. This assistance includes a hotline manned by professionals who can help with billing as well as coding, insurance assistance like benefit inquiries, earlier approval, and claims reviews.

National Institutes of Health introduced a programme called Nutrition for Precision Health to enlist 10,000 different people as part of its All of Us Research Program

On January 21^th, 2022; The National Institutes of Health introduced a program called Nutrition for Precision Health that will enlist 10,000 different people as part of its All of Us Research Program to provide more individualized nutrition advice. A new project that will create algorithms to forecast individual reactions to food and dietary habits will get funding from the NIH in the amount of $170 million over five years from clinics and centers around the nation.

Consumer Healthcare Products Association (CHPA) Launched The Dietary Supplements Index (DSX), a Network That Disseminates Market Information Regarding Developments In Health And Nutritional Supplements

On March 25^th, 2022; The Dietary Supplements Index (DSX), a network that disseminates market information regarding developments in health and nutritional supplements, was created by the Consumer Healthcare Products Association (CHPA).

It aspires to use this as evidence to persuade lawmakers, insurers, and companies to include dietary supplements in the scope of US healthcare. The CHPA states that the tool may be utilized to urge medical professionals to suggest dietary additives to clients as a part of their regular health regimen. The main resource for the DSX was Spins, a US-based wellness-focused data, analysis, and technological firm.

Report Analysis	Details
Historical data	2016 - 2021
Forecast Period	2022 - 2029
Market Size in 2021:	USD 11.8 Billion
Base year considered	2021
Forecast Period CAGR %:	8%
Market Size Expected in 2028:	USD 20.1 Billion
Tables, Charts & Figures:	175
Pages	300
Key Players/Companies	Nestlé SA, Danone, Abbott Laboratories, B. Braun Melsungen AG, Pfizer, Baxter Healthcare Ltd., Hospira, Fresenius Kabi, Perrigo Company PLC., and Mead Johnson Nutrition Company
Segments Covered	By Product, By Consumer, By Application, By Distribution Channel
Regional Analysis	North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa